Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Chirurgia Polska
MENU
Na skróty Zdeponuj artykuł Wytyczne dla autorów Ahead of print Recenzenci 2023

Tom 23, Nr 1-2 (2021)
Praca badawcza (oryginalna)
Opublikowany online: 2022-12-30
Dodaj do koszyka: 49,00 PLN
Pobierz cytowanie

Prospective observation of neurological symptoms attributable to cerebral hyperfusion syndrome after CEA and CAS

Damian Ziaja12, Mariola Sznapka34, Grzegorz Biolik5, Anetta Lasek-Bal6, Danuta Gierek7, Wacław Kuczmik8, Tomasz Gul9, Jerzy Chudek10, Krzysztof Ziaja114
DOI: 10.5603/ChP.2021.0007
·
Chirurgia Polska 2021;23(1-2):11-16.
Afiliacje
  1. Department of Physiotherapy Medical University of Silesia in Katowice
  2. Department of General and Oncological Surgery, MEGREZ Tychy
  3. Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia
  4. Katowice Business University Medical Science Faculty
  5. Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia
  6. Department of Stroke and Neurology SPSK n. 7 , Katowice
  7. Department of Intensive Therapy and Anesthesiology SPSK n. 7, Katowice
  8. Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia
  9. Department of General, Vascular Surgery, Angiology and Phlebology Faculty of Katowice Medical University of Silesia
  10. Department of Internal and Onkological Medicine WLK SUM, Katowice
  11. Department of General and Oncological Surgery, MEGREZ, Tychy

dostęp płatny

Tom 23, Nr 1-2 (2021)
Prace oryginalne
Opublikowany online: 2022-12-30

Streszczenie

Introduction: Neurological symptoms are considered as most clinically significant symptoms with various
pathogenesis, including cerebral hyperperfusion syndrome (CHS) and microembolism, in patients shortly
after endarterectomy (CEA) and stenting (CAS) for internal carotid artery stenosis (ICA).

Aim: This study aimed to compare the structure of neurological symptoms attributable to CHS after carotid
artery revascularization collected retrospectively and prospectively in large patient cohorts.

Material and methods: Prospective analysis included 1047 consecutive patients treated with CEA (n =
477) or CSA (n = 570) in a single centre from 2011 to 2015. In 2012 was introduced strict monitoring of
pain in patients with headache and blood pressure (BP) and more intensive antihypertensive treatment in
patients with an increase in BP post-procedure. The occurrence of neurological symptoms attributable to
CHS was compared with a historical, retrospectively analysed less strictly monitored cohort (n = 1386).

Results: Neurological symptoms attributed to CHS were observed less frequently in prospectively than
retrospectively analysed cohort: 8.3% vs 10.6% (p = 0.03) of CEA and 5.7% vs 8.0% (p = 0.10) of CAS
group, respectively. The profile of neurological symptoms was similar in both cohorts. The prospective
analysis revealed more episodes of transient bradycardia and/or hypotension in the CAS group (10.4 vs
8.8% and 11.2 vs 9.2%, respectively).

Conclusion: The incidence of neurological symptoms attributable to cerebral hyperperfusion syndrome
after carotid artery revascularization in short-term observation is similar regardless of the method used.
Strict monitoring of BP slightly decreased the prevalence of neurological symptoms after carotid artery
revascularization.

Streszczenie

Introduction: Neurological symptoms are considered as most clinically significant symptoms with various
pathogenesis, including cerebral hyperperfusion syndrome (CHS) and microembolism, in patients shortly
after endarterectomy (CEA) and stenting (CAS) for internal carotid artery stenosis (ICA).

Aim: This study aimed to compare the structure of neurological symptoms attributable to CHS after carotid
artery revascularization collected retrospectively and prospectively in large patient cohorts.

Material and methods: Prospective analysis included 1047 consecutive patients treated with CEA (n =
477) or CSA (n = 570) in a single centre from 2011 to 2015. In 2012 was introduced strict monitoring of
pain in patients with headache and blood pressure (BP) and more intensive antihypertensive treatment in
patients with an increase in BP post-procedure. The occurrence of neurological symptoms attributable to
CHS was compared with a historical, retrospectively analysed less strictly monitored cohort (n = 1386).

Results: Neurological symptoms attributed to CHS were observed less frequently in prospectively than
retrospectively analysed cohort: 8.3% vs 10.6% (p = 0.03) of CEA and 5.7% vs 8.0% (p = 0.10) of CAS
group, respectively. The profile of neurological symptoms was similar in both cohorts. The prospective
analysis revealed more episodes of transient bradycardia and/or hypotension in the CAS group (10.4 vs
8.8% and 11.2 vs 9.2%, respectively).

Conclusion: The incidence of neurological symptoms attributable to cerebral hyperperfusion syndrome
after carotid artery revascularization in short-term observation is similar regardless of the method used.
Strict monitoring of BP slightly decreased the prevalence of neurological symptoms after carotid artery
revascularization.

Pełny tekst:

Dodaj do koszyka: 49,00 PLN
Pobierz cytowanie

Słowa kluczowe

cerebral hyperperfusion syndrome (CHS); carotid artery revascularization; carotid endarterectomy (CEA); carotid artery stenting (CAS)

Informacje o artykule
Tytuł

Prospective observation of neurological symptoms attributable to cerebral hyperfusion syndrome after CEA and CAS

Czasopismo

Chirurgia Polska

Numer

Tom 23, Nr 1-2 (2021)

Typ artykułu

Praca badawcza (oryginalna)

Strony

11-16

Opublikowany online

2022-12-30

Wyświetlenia strony

3086

Wyświetlenia/pobrania artykułu

15

DOI

10.5603/ChP.2021.0007

Rekord bibliograficzny

Chirurgia Polska 2021;23(1-2):11-16.

Słowa kluczowe

cerebral hyperperfusion syndrome (CHS)
carotid artery revascularization
carotid endarterectomy (CEA)
carotid artery stenting (CAS)

Autorzy

Damian Ziaja
Mariola Sznapka
Grzegorz Biolik
Anetta Lasek-Bal
Danuta Gierek
Wacław Kuczmik
Tomasz Gul
Jerzy Chudek
Krzysztof Ziaja

Referencje (38)
  1. Chambers BR, Donnan GA, Chambers BR, et al. Carotid endarterectomy for asymptomatic carotid stenosis. Cochrane Database Syst Rev. 2000(2): CD001923.
    CrossRefPubMed
  2. Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev 2000(2):CD001081. .
    CrossRefPubMed
  3. CAVATAS Investigators. Endovascular versus surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomized trial. Lancet. 2001; 357: 1729–1737.
    PubMed
  4. Yadav JS, Wholey MH, Kuntz RE, et al. Stenting and Angioplasty with Protection in Patients at High Risk for Endarterectomy Investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004; 351(15): 1493–1501.
    CrossRefPubMed
  5. Newman JE, Ali M, Sharpe R, et al. Seizures after carotid endarterectomy: hyperperfusion, dysautoregulation or hypertensive encephalopathy? Eur J Vasc Endovasc Surg. 2003; 26(1): 39–44.
    CrossRefPubMed
  6. Jørgensen LG, Schroeder TV. Defective cerebrovascular autoregulation after carotid endarterectomy. Eur J Vasc Surg. 1993; 7(4): 370–379.
    CrossRefPubMed
  7. Schwartz RB. Hyperperfusion encephalopathies: hypertensive encephalopathy and related conditions. Neurologist. 2002; 8(1): 22–34.
    CrossRefPubMed
  8. Sundt TM. Jr, Sharbrough FW, Piepgras DG, Kearns TP, Messick JM Jr, O'Fallon WM. Correlation of cerebral blood flow and electroencephalographic changes during carotid endarterectomy: with results of surgery and hemodynamics of cerebral ischaemia. Mayo Clin Proc. 1981; 56: 533–543.
    PubMed
  9. McCabe DJ, Brown MM, Clifton A. Fatal cerebral reperfusion hemorrhage after carotid stenting. Stroke. 1999; 30(11): 2483–2486.
    CrossRefPubMed
  10. Wu T, Anderson N, Barber P. Neurological complications of carotid revascularization. J Neurol Neurosurg Psychiatry. 2012; 83: 543–550.
    CrossRefPubMed
  11. Dunne VG, Besser M, Ma WJ. Transcranial Doppler in carotid endarterectomy. J Clin Neurosci. 2001; 8(2): 140–145.
    CrossRefPubMed
  12. Beard JD, Mountney J, Wilkinson JM, et al. Prevention of postoperative wound haematomas and hyperperfusion following carotid endarterectomy. Eur J Vasc Endovasc Surg. 2001; 21(6): 490–493.
    CrossRefPubMed
  13. Ziaja D, Biolik G, Kocełak P, et al. Ziaja K. Neurological symptoms associated with cerebral hyperperfusion syndrome after CEA and CAS – one center study. Eur Rev Med Pharmacol Sci. 2014; 18: 1176–1180.
    PubMed
  14. Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997; 26(3): 517–538.
    CrossRefPubMed
  15. Denzel C, Balzer K, Müller KM, et al. Relative value of normalized sonographic in vitro analysis of arteriosclerotic plaques of internal carotid artery. Stroke. 2003; 34(8): 1901–1906.
    CrossRefPubMed
  16. Ogasawara K, Sakai N, Kuroiwa T, et al. Japanese Society for Treatment at Neck in Cerebrovascular Disease Study Group. Intracranial hemorrhage associated with cerebral hyperperfusion syndrome following carotid endarterectomy and carotid artery stenting: retrospective review of 4494 patients. J Neurosurg. 2007; 107(6): 1130–1136.
    CrossRefPubMed
  17. Brantley HP, Kiessling JL, Milteer HB, et al. Hyperperfusion syndrome following carotid artery stenting: the largest single-operator series to date. J Invasive Cardiol. 2009; 21(1): 27–30.
    PubMed
  18. Coutts SB, Hill MD, Hu WY. Hyperperfusion syndrome: toward a stricter definition. Neurosurgery. 2003; 53: 1053–1060.
    CrossRefPubMed
  19. Meyers PM, Higashida RT, Phatouros CC, et al. Cerebral hyperperfusion syndrome after percutaneous transluminal stenting of the craniocervical arteries. Neurosurgery. 2000; 47(2): 335–43; discussion 343.
    CrossRefPubMed
  20. Abou-Chebl A, Reginelli J, Bajzer CT, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid artery stenting: risk factors, prevention, and treatment. J Am Coll Cardiol. 2004; 43(9): 1596–1601.
    CrossRefPubMed
  21. Shields RC. Medical management of carotid stenosis. Perspect Vasc Surg Endovasc Ther. 2010; 22(1): 18–27.
    CrossRefPubMed
  22. Yoshimoto T, Shirasaka T, Yoshizumi T, et al. Evaluation of carotid distal pressure for prevention of hyperperfusion after carotid endarterectomy. Surg Neurol. 2005; 63(6): 554–7; discussion 557.
    CrossRefPubMed
  23. Karapanayiotides T, Meuli R, Devuyst G, et al. Postcarotid endarterectomy hyperperfusion or reperfusion syndrome. Stroke. 2005; 36(1): 21–26.
    CrossRefPubMed
  24. van Mook WN, Rennenberg RJ, Schurink GW, et al. Cerebral hyperperfusion syndrome. Lancet Neurol. 2005; 4(12): 877–888.
    CrossRefPubMed
  25. Tehindrazanarivelo AD, Lutz G, PetitJean C, et al. Headache following carotid endarterectomy: a prospective study. Cephalalgia. 1992; 12(6): 380–382.
    CrossRefPubMed
  26. Qureshi AI, Luft AR, Sharma M, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke. 1999; 30(10): 2086–2093.
    CrossRefPubMed
  27. Harrop JS, Sharan AD, Benitez RP, et al. Prevention of carotid angioplasty-induced bradycardia and hypotension with temporary venous pacemakers. Neurosurgery. 2001; 49(4): 814–20; discussion 820.
    CrossRefPubMed
  28. Hines LH, DeCrosta D, Kantaria S, et al. Ch., Islam S. Postendarterectomy cerebral hyperperfusion sundrome: the etiological significance of “cerebral Reserve”. Int.J.Angiol 2014; (4) 23:125–130. .
    CrossRefPubMed
  29. Mondel PK, Udare AS, Anand SV, et al. Recurrent cerebral hyperperfusion syndrome after intracranial angioplasty and stenting: case report with review of literature. Cardiovasc Intervent Radiol. 2014; 37(4): 1087–1092.
    CrossRefPubMed
  30. Isozaki M, Arai Y, Higashino Y, et al. Cerebral hyperperfusion syndrome resulting in subarachnoid hemorrhage after carotid artery stenting. Ann Nucl Med. 2016; 30(9): 669–674.
    CrossRefPubMed
  31. Oh SI, Lee SJ, Lee YJ, et al. Delayed cerebral hyperperfusion syndrome three weeks after carotid artery stenting presenting as status epilepticus. J Korean Neurosurg Soc. 2014; 56(5): 441–443.
    CrossRefPubMed
  32. Lin TW, Wang JN. Kan ChD. Cerebral hyperperfusion sundrome after surgical repair congenital supravascu;ar aortic stenosis. Ann Thorac Surg. 2015; 100: 51.
  33. Narita S, Aikawa H, Nagata SI, et al. Intraprocedural prediction of hemorrhagic cerebral hyperperfusion syndrome after carotid artery stenting. J Stroke Cerebrovasc Dis. 2013; 22(5): 615–619.
    CrossRefPubMed
  34. Mass M, Kwolek HJ, Hirsch JA, et al. Clinicl risk predictors for cerebral hyperperfusion syndrome after carotid endarterectomy. J Neurol Neurosurg Psychiatry. 2013; 84: 569–72.
    CrossRefPubMed
  35. Lai ZH, Liu B, Chen Y, et al. Prediction of vertebral hyperperfusion syndrome with velocity blood pressure index. http//www.cmj.org on January 18. 2017 , IP 213 227. ; 113: 51.
  36. Kim KH, Lee CH, Son YJ, et al. Post-carotid endarterectomy cerebral hyperperfusion syndrome : is it preventable by strict blood pressure control? J Korean Neurosurg Soc. 2013; 54(3): 159–163.
    CrossRefPubMed
  37. Fujimoto M, Itokawa H, Moriya M, et al. Evaluation of Cerebral Hyperperfusion After Carotid Artery Stenting Using C‑Arm CT Measurements of Cerebral Blood Volume. Clin Neuroradiol. 2018; 28(2): 253–260.
    CrossRefPubMed
  38. Lin YH, Liu HM. Update on cerebral hyperperfusion syndrome. J Neurointerv Surg. 2020; 12(8): 788–793.
    CrossRefPubMed

Regulamin

Ważne: serwis https://journals.viamedica.pl/ wykorzystuje pliki cookies. Więcej >>

Używamy informacji zapisanych za pomocą plików cookies m.in. w celach statystycznych, dostosowania serwisu do potrzeb użytkownika (np. język interfejsu) i do obsługi logowania użytkowników. W ustawieniach przeglądarki internetowej można zmienić opcje dotyczące cookies. Korzystanie z serwisu bez zmiany ustawień dotyczących cookies oznacza, że będą one zapisane w pamięci komputera. Więcej informacji można znaleźć w naszej Polityce prywatności.

Czym są i do czego służą pliki cookie możesz dowiedzieć się na stronie wszystkoociasteczkach.pl.

Czasopismo Chirurgia Polska dostęne jest również w Ikamed - księgarnia medyczna

Wydawcą serwisu jest VM Media Group sp. z o.o, Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl